When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 42 Hits
  • Search Condition : Filter (MeSH = Neoplasms / drug therapy)
Species Resource Title
Human and Animal Cells NALM6(RCB1933) , PK45H(RCB1973) , LC-2/ad(RCB0440) Immunoregulation by IL-7R-targeting antibody-drug conjugates: overcoming steroid-resistance in cancer and autoimmune disease.
Human and Animal Cells TE-8(RCB2098) , TE-10(RCB2099) Targeting p300 Addiction in CBP-Deficient Cancers Causes Synthetic Lethality by Apoptotic Cell Death due to Abrogation of MYC Expression.
Human and Animal Cells ECC10(RCB0983) E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling.
Human and Animal Cells MKN28(RCB1000) Metastasis Associated Lung Adenocarcinoma Transcript 1: An update on expression pattern and functions in carcinogenesis.
Human and Animal Cells MIA Paca2(RCB2094) , HuCCT1(RCB1960) Effects of Pre- and Post-Administration of Vitamin A on the Growth of Refractory Cancers in Xenograft Mice.
Human and Animal Cells MIA Paca2(RCB2094) , HuCCT1(RCB1960) Inhibitory Effects of Retinol Are Greater than Retinoic Acid on the Growth and Adhesion of Human Refractory Cancer Cells.
Human and Animal Cells LLC(RCB0558) Polaprezinc reduces paclitaxel-induced peripheral neuropathy in rats without affecting anti-tumor activity.
Human and Animal Cells MKN45(RCB1001) In Vitro and In Vivo Activity of AMG 337, a Potent and Selective MET Kinase Inhibitor, in MET-Dependent Cancer Models.
Human and Animal Cells CACO-2(RCB0988) Immunoprotective effect of epigallocatechin-3-gallate on oral anticancer drug-induced α-defensin reduction in Caco-2 cells.
Human and Animal Cells HCT116(RCB2979), MKN45(RCB1001) Dimethyl Fumarate Attenuates Oxaliplatin-Induced Peripheral Neuropathy without Affecting the Anti-tumor Activity of Oxaliplatin in Rodents.
Human and Animal Cells HCT116(RCB2979), CHO-K1 Feline XLF accumulates at DNA damage sites in a Ku-dependent manner.
Human and Animal Cells TUHR4TKB(RCB1198) Differential metabolic activity and discovery of therapeutic targets using summarized metabolic pathway models.
Human and Animal Cells KP4(RCB1005) Synthetic Lethal Interaction of SHOC2 Depletion with MEK Inhibition in RAS-Driven Cancers.
Human and Animal Cells HeLa(RCB0007) Propagermanium Induces NK Cell Maturation and Tends to Prolong Overall Survival of Patients With Refractory Cancer.
Human and Animal Cells KP4(RCB1005) Population Pharmacokinetics of Liposomal Irinotecan in Patients With Cancer.
Human and Animal Cells MCF7(RCB1904) Development of drug-loaded protein nanoparticles displaying enzymatically-conjugated DNA aptamers for cancer cell targeting.
Human and Animal Cells COS-7(RCB0539) Structure and mechanism of cancer-associated N-acetylglucosaminyltransferase-V.
C.elegans tm1944 An Ancient, Unified Mechanism for Metformin Growth Inhibition in C. elegans and Cancer.
Human and Animal Cells A549(RCB0098) , HCT116(RCB2979) , COLO205(RCB2127) Mechanism of recipient cell-dependent differences in exosome uptake.
Human and Animal Cells L5178Y(RCB0135) Caspase-mediated cleavage of X-ray repair cross-complementing group 4 promotes apoptosis by enhancing nuclear translocation of caspase-activated DNase.